vs

Side-by-side financial comparison of Danaher Corporation (DHR) and US Foods Holding Corp. (USFD). Click either name above to swap in a different company.

US Foods Holding Corp. is the larger business by last-quarter revenue ($9.8B vs $6.0B, roughly 1.6× Danaher Corporation). Danaher Corporation runs the higher net margin — 17.3% vs 1.9%, a 15.4% gap on every dollar of revenue. On growth, Danaher Corporation posted the faster year-over-year revenue change (3.7% vs 3.3%). Danaher Corporation produced more free cash flow last quarter ($1.1B vs $159.0M). Over the past eight quarters, US Foods Holding Corp.'s revenue compounded faster (4.6% CAGR vs 1.8%).

Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments,...

US Foods Holding Corp. is an American food service distributor. It is the second-largest food service distributor in the U.S., after Sysco. The company supplies 250,000 locations including independent restaurants, chain restaurants, healthcare, hospitality, and educational institutions.

DHR vs USFD — Head-to-Head

Bigger by revenue
USFD
USFD
1.6× larger
USFD
$9.8B
$6.0B
DHR
Growing faster (revenue YoY)
DHR
DHR
+0.4% gap
DHR
3.7%
3.3%
USFD
Higher net margin
DHR
DHR
15.4% more per $
DHR
17.3%
1.9%
USFD
More free cash flow
DHR
DHR
$926.0M more FCF
DHR
$1.1B
$159.0M
USFD
Faster 2-yr revenue CAGR
USFD
USFD
Annualised
USFD
4.6%
1.8%
DHR

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
DHR
DHR
USFD
USFD
Revenue
$6.0B
$9.8B
Net Profit
$1.0B
$184.0M
Gross Margin
60.3%
17.6%
Operating Margin
22.6%
3.3%
Net Margin
17.3%
1.9%
Revenue YoY
3.7%
3.3%
Net Profit YoY
7.9%
178.8%
EPS (diluted)
$1.45
$0.82

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DHR
DHR
USFD
USFD
Q1 26
$6.0B
Q4 25
$6.8B
$9.8B
Q3 25
$6.1B
$10.2B
Q2 25
$5.9B
$10.1B
Q1 25
$5.7B
$9.4B
Q4 24
$6.5B
$9.5B
Q3 24
$5.8B
$9.7B
Q2 24
$5.7B
$9.7B
Net Profit
DHR
DHR
USFD
USFD
Q1 26
$1.0B
Q4 25
$1.2B
$184.0M
Q3 25
$908.0M
$153.0M
Q2 25
$555.0M
$224.0M
Q1 25
$954.0M
$115.0M
Q4 24
$1.1B
$66.0M
Q3 24
$818.0M
$148.0M
Q2 24
$907.0M
$198.0M
Gross Margin
DHR
DHR
USFD
USFD
Q1 26
60.3%
Q4 25
58.0%
17.6%
Q3 25
58.2%
17.2%
Q2 25
59.3%
17.6%
Q1 25
61.2%
17.3%
Q4 24
59.5%
17.6%
Q3 24
58.7%
17.1%
Q2 24
59.7%
17.6%
Operating Margin
DHR
DHR
USFD
USFD
Q1 26
22.6%
Q4 25
22.0%
3.3%
Q3 25
19.1%
2.8%
Q2 25
12.8%
3.7%
Q1 25
22.2%
2.4%
Q4 24
21.8%
3.2%
Q3 24
16.5%
2.9%
Q2 24
20.3%
3.6%
Net Margin
DHR
DHR
USFD
USFD
Q1 26
17.3%
Q4 25
17.5%
1.9%
Q3 25
15.0%
1.5%
Q2 25
9.3%
2.2%
Q1 25
16.6%
1.2%
Q4 24
16.6%
0.7%
Q3 24
14.1%
1.5%
Q2 24
15.8%
2.0%
EPS (diluted)
DHR
DHR
USFD
USFD
Q1 26
$1.45
Q4 25
$1.69
$0.82
Q3 25
$1.27
$0.67
Q2 25
$0.77
$0.96
Q1 25
$1.32
$0.49
Q4 24
$1.50
$0.28
Q3 24
$1.12
$0.61
Q2 24
$1.22
$0.80

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DHR
DHR
USFD
USFD
Cash + ST InvestmentsLiquidity on hand
$41.0M
Total DebtLower is stronger
$5.1B
Stockholders' EquityBook value
$4.3B
Total Assets
$13.9B
Debt / EquityLower = less leverage
1.18×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DHR
DHR
USFD
USFD
Q1 26
Q4 25
$41.0M
Q3 25
$56.0M
Q2 25
$61.0M
Q1 25
$101.0M
Q4 24
$59.0M
Q3 24
$81.0M
Q2 24
$405.0M
Total Debt
DHR
DHR
USFD
USFD
Q1 26
Q4 25
$18.4B
$5.1B
Q3 25
$16.9B
$4.8B
Q2 25
$17.4B
$4.7B
Q1 25
$16.5B
$4.7B
Q4 24
$16.0B
$4.8B
Q3 24
$17.5B
$4.7B
Q2 24
$17.0B
$4.6B
Stockholders' Equity
DHR
DHR
USFD
USFD
Q1 26
Q4 25
$52.5B
$4.3B
Q3 25
$51.1B
$4.5B
Q2 25
$52.3B
$4.6B
Q1 25
$50.8B
$4.6B
Q4 24
$49.5B
$4.5B
Q3 24
$51.3B
$4.6B
Q2 24
$49.9B
$5.0B
Total Assets
DHR
DHR
USFD
USFD
Q1 26
Q4 25
$83.5B
$13.9B
Q3 25
$79.9B
$14.0B
Q2 25
$81.6B
$13.8B
Q1 25
$79.1B
$13.7B
Q4 24
$77.5B
$13.4B
Q3 24
$80.6B
$13.5B
Q2 24
$78.6B
$13.7B
Debt / Equity
DHR
DHR
USFD
USFD
Q1 26
Q4 25
0.35×
1.18×
Q3 25
0.33×
1.08×
Q2 25
0.33×
1.02×
Q1 25
0.32×
1.02×
Q4 24
0.32×
1.06×
Q3 24
0.34×
1.01×
Q2 24
0.34×
0.92×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DHR
DHR
USFD
USFD
Operating Cash FlowLast quarter
$1.3B
$293.0M
Free Cash FlowOCF − Capex
$1.1B
$159.0M
FCF MarginFCF / Revenue
18.2%
1.6%
Capex IntensityCapex / Revenue
4.0%
1.4%
Cash ConversionOCF / Net Profit
1.28×
1.59×
TTM Free Cash FlowTrailing 4 quarters
$5.3B
$959.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DHR
DHR
USFD
USFD
Q1 26
$1.3B
Q4 25
$2.1B
$293.0M
Q3 25
$1.7B
$351.0M
Q2 25
$1.3B
$334.0M
Q1 25
$1.3B
$391.0M
Q4 24
$2.0B
$283.0M
Q3 24
$1.5B
$270.0M
Q2 24
$1.4B
$482.0M
Free Cash Flow
DHR
DHR
USFD
USFD
Q1 26
$1.1B
Q4 25
$1.7B
$159.0M
Q3 25
$1.4B
$236.0M
Q2 25
$1.1B
$257.0M
Q1 25
$1.1B
$307.0M
Q4 24
$1.5B
$178.0M
Q3 24
$1.2B
$190.0M
Q2 24
$1.1B
$413.0M
FCF Margin
DHR
DHR
USFD
USFD
Q1 26
18.2%
Q4 25
25.5%
1.6%
Q3 25
22.6%
2.3%
Q2 25
18.4%
2.5%
Q1 25
18.4%
3.3%
Q4 24
23.0%
1.9%
Q3 24
21.0%
2.0%
Q2 24
19.7%
4.3%
Capex Intensity
DHR
DHR
USFD
USFD
Q1 26
4.0%
Q4 25
5.4%
1.4%
Q3 25
4.8%
1.1%
Q2 25
4.2%
0.8%
Q1 25
4.3%
0.9%
Q4 24
7.9%
1.1%
Q3 24
5.1%
0.8%
Q2 24
5.0%
0.7%
Cash Conversion
DHR
DHR
USFD
USFD
Q1 26
1.28×
Q4 25
1.77×
1.59×
Q3 25
1.83×
2.29×
Q2 25
2.41×
1.49×
Q1 25
1.36×
3.40×
Q4 24
1.86×
4.29×
Q3 24
1.85×
1.82×
Q2 24
1.56×
2.43×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DHR
DHR

Segment breakdown not available.

USFD
USFD

Product One$3.5B36%
Product Two$1.7B17%
Product Three$1.7B17%
Product Four$985.0M10%
Product Five$901.0M9%
Product Six$580.0M6%
Product Seven$485.0M5%

Related Comparisons